

Serina Therapeutics Inc. surged 39.45% in after-hours trading Wednesday following a $15 million private placement announcement.
You can purchase shares of Serina Therapeutics (AMEX:SER) through any online brokerage.
Other companies in Serina Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Serina Therapeutics has a consensus price target of $11.33.
The stock price for Serina Therapeutics (AMEX: SER) is $ last updated .
There are no upcoming dividends for Serina Therapeutics.
Serina Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Serina Therapeutics.
Serina Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in...